MACRAMÉ Publication Portfolio
The MACRAMÉ Consortium produced multiple open access publications that collectively underpin the Project’s scientific and technological advances and achievements. Access the full list of publications here.
The MACRAMÉ Consortium produced multiple open access publications that collectively underpin the Project’s scientific and technological advances and achievements. Access the full list of publications here.
The MACRAMÉ Project has developed twelve recommendations to address gaps in AdMas characterisation & identification, safety testing, transformation & release, and information flow.
Adverse health effects can be caused by inhaled particles. These inhaled particles can induce persistent pulmonary inflammation when macrophage-mediated clearance mechanisms are overwhelmed.
MACRAMÉ colleagues from BAuA and IBE together with experts from the German BfR have published an extensive study on the behaviour of Macrophages when they encounter fibres.
Experts from the MACRAMÉ Partner University of Birmingham published a paper on the PM2.5-induced multinucleation of bronchial epithelial Cells caused by microtubule overacetylation and disruption of microtubule-associated proteins.
MACRAMÉ Project Partners AcumenIST have published an article about the discussions and conclusions of a workshop that elucidated how Artificial Intelligence (AI) is increasingly influencing chemical risk assessment, enabling faster, more comprehensive, and potentially more ethical assessments.
MACRAMÉ experts from University of Birmingham contributed to a new publication on the impact of common microplastic extraction methods.
MACRAMÉ Experts from University of Birmingham and 7Past9 together with many other experts published an article on challenges and future directions in assessing the quality and completeness of advanced materials safety data for re-usability.
MACRAMÉ colleagues from EMPA contributed to the publication ‘Boron Nitride Nanomaterials Trigger Immunomodulatory Effects in Human Broncho-Epithelial Cells by Modulating Eicosanoid Lipid Signaling’. For the successful commercial development of emerging 2D materials, it is crucial to understand their potential biological effects on healthy and diseased individuals.
The ‘Joint Risk Assessor Summit on Advancing Safety & Sustainability Assessments of Advanced Materials’ hosted at the Organisation for Economic Cooperation and Development (OECD) in Paris and co-organised by four Horizon Europe projects ACCORDs, iCARE, MACRAMÉ, and nanoPASS, was a full success. Now, the full report of the event is available.